Join
Live feed
·
INSIDERFilingvia Quantisnow
Summit Therapeutics Inc. logo

Co-Chief Executive Officer Duggan Robert W was granted 3,325,991 shares, increasing direct ownership by 0.61% to 551,695,096 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SMMT· Summit Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SMMT (Summit Therapeutics Inc.) and more on Quantisnow.